Search Results
Feb 21, 2026, 08:00 ET TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
impact patients' overall health and they need treatment options that remain effective and well-tolerated over time," said Laurent Peyrin-Biroulet, MD, PhD, study investigator.e "The QUASAR long-term study shows the sustained ability of TREMFYA to deliver durable results, with consistent outcomes
More news about: Johnson & Johnson
Feb 20, 2026, 16:51 ET Revision Skincare® DEJ Daily Boosting Serum™ Wins Advanced Clinical Beauty & Performance Category at the 2025-2026 Beauty & Longevity CHOICE Awards
this recognition underscores Revision Skincare®'s commitment to developing clinically proven, high‑performance skincare," said Alisar Zahr, PhD, VP of Research and Clinical Development, Revision Skincare®. "DEJ Daily Boosting Serum™ was formulated to deliver measurable improvements
More news about: Revision Skincare
Feb 20, 2026, 10:58 ET Discovery Could Make Immune Checkpoint Inhibitors Safer
the Study Cincinnati Children's co-authors also included Anne Katrine Johansen, PhD, Mengchi Jiao, PhD, Megan Linnemann, BS, Irene Saha, PhD, Suh-Chin Lin, PhD, Charles Vallez, BS, and Thomas Hagan, PhD. These core services also contributed to the study: the Veterinary Services Facility, Research
More news about: Cincinnati Children's Hospital Medical Center
Feb 20, 2026, 10:00 ET New England Biolabs® to present latest updates in Next Generation Sequencing Sample Preparation at 2026 AGBT Meeting
New England Biolabs, Inc. and Neeman Mohibullah, PhD., Director, Integrated Genomics OperationMemorial
More news about: New England Biolabs, Inc.
Feb 20, 2026, 08:00 ET Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy Trial
advanced NRG1 fusion-positive non-small cell lung cancer often have limited treatment options after progression," said Dr. Misako Nagasaka, MD, PhD of the University of California Irvine and senior author. "In this analysis, continued zenocutuzumab treatment beyond RECIST progression provided meaningful,
More news about: Partner Therapeutics, Inc.
Feb 19, 2026, 16:54 ET Creating Healthier Communities Names Dr. Mya O. Price as Executive Vice President & Chief Social Impact Officer
investment."Dr. Price brings the vision, discipline, and collaborative spirit needed to accelerate CHC's work across sectors," said Jean Accius, PhD, President and CEO at CHC. "Her ability to unite partners around shared outcomes and translate community-informed insights into measurable impact will
More news about: Creating Healthier Communities
Feb 19, 2026, 16:47 ET ASTHO Partners with Veritas Data Research and HealthVerity to Launch the First-of-its-Kind Public Health Data Consortium
private and public entities together to address the gaps that plague our nation's public health data and technology infrastructure," said Jen Layden, MD, PhD, ASTHO senior vice president of population and innovation, and former CDC and state public health leader. "This consortium, by uniting on a common mission
More news about: Association of State and Territorial Health Officials
Feb 19, 2026, 15:22 ET Two Male Birth Control Options Advance Into Phase II Clinical Trials
Darlene Walley, PhD, Chief Executive Officer of NEXT Life Sciences. "Since over 20 percent of women cannot tolerate hormonal birth control, in some cases with severe
More news about: NEXT Life Sciences, Inc.
Feb 19, 2026, 13:58 ET Dr. Marcus Goncalves Named Director of NYU Langone's Holman Division of Endocrinology, Diabetes, & Metabolism
Marcus D. Goncalves, MD, PhD, has been appointed director of the
More news about: NYU Langone Health
Feb 19, 2026, 12:36 ET Rosalind Franklin University Innovation and Research Park Welcomes Clinical Research Organization's Phase I/II Clinical Site
infrastructure, which also includes our immediate neighbor, the Lovell Federal Health Care Center, part of the Great Lakes Naval Base," said Janice Urban, PhD, RFU's interim executive vice president for research. "We see great synergies with our medical, pharmacy and nursing schools. Additionally, CCRII fills
More news about: Rosalind Franklin University of Medicine and Science
Feb 19, 2026, 12:22 ET Boyd présentera son leadership en refroidissement liquide au salon Data Centre World London 2026
AI, les environnements de colocation et les opérateurs à grande échelle. Boyd proposera également une session de conférences de Ryan J. McGlen, CEng, PhD, qui présentera « Architecting the Data Center Cooling Circuit from 'Chip-to-Ambient'™ », offrant un aperçu technique de la conception future du refroidissement
More news about: Boyd Corporation
Feb 19, 2026, 11:06 ET Unicity Labs Raises $3M to Scale Autonomous Agentic Marketplaces
intermediaries or shared ledgers.The Unicity Labs team, which previously built and exited Guardtime, a cybersecurity infrastructure company, includes PhD researchers in distributed systems, cryptography, and machine learning. The company recently established the Unicity Foundation in Switzerland to oversee
More news about: Unicity Labs
Feb 19, 2026, 11:00 ET With Stagnant Veteran Suicide Rates, SHEEPDOG, Now On Demand, Calls on Americans to Support Department of Veterans Affairs Prevention Efforts
Dr. Anthony Estreet, PhD, MBA, LCSW-C, CEO of the National Association of Social Workers. "We want every veteran to know they are part of a community that values their strength
More news about: Sheepdog The Movie
Feb 19, 2026, 10:15 ET OneSchool Global Appoints Dr. Anat Hassner as Chief Operating Officer to Lead Global Strategy
complex global environments. Her career spans consulting, technology, retail, transport, infrastructure, government, and nonprofit sectors. She holds a PhD in Change Management and a Master of Organizational Psychology, and is a published author on change leadership."Anat brings an extraordinary blend
More news about: OneSchool Global
Feb 19, 2026, 10:12 ET Science-of-Reading Instruction Helps Student Overcome Dyslexia and Become A Published Author
of what the speech-to-print methodology empowered in her son's skills."Dyslexia is not a lifetime sentence," said Dr. Tim Conway, PhD, founder of NOW! Programs®. "With RCT evidence-based speech-to-print instruction, children can reach grade-level reading and beyond."Jacob
More news about: NOW! Programs®
Feb 19, 2026, 09:00 ET Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
modulate individual biomarkers—it impacts the core biological processes that define MASH, including fibrosis and inflammation," said Dr. André P. Boulet, PhD, Chief Executive Officer of Devonian. "Together with our previously reported mouse STAM® data, this study strengthens the translational rationale for
More news about: Devonian Health Group Inc.
Feb 19, 2026, 08:00 ET Stellaromics Launches Pyxa™ at AGBT, the First Commercial Platform for 3D Spatial Multi-Omics in Intact Tissue
Florida."Every spatial transcriptomics platform on the market today forces researchers to infer 3D biology from flat sections," said Todd Dickinson, PhD, Chief Executive Officer of Stellaromics. "Our goal was to eliminate that compromise. Today we are thrilled to announce the official launch of Pyxa,
More news about: Stellaromics
Feb 19, 2026, 08:00 ET Ten63 Therapeutics Closes Strategic Financing, Bringing Total Funding to More Than $45M to Scale the Next-Generation of Artificial Intelligent Drug Discovery
them exceptionally difficult for traditional experimental screening and current AI techniques. They require a new approach," said Marcel Frenkel, PhD, CEO of Ten63 Therapeutics. Powered by BEYOND, the company is pursuing a pipeline of first- and best-in-class small molecules against some of
More news about: Ten63 Therapeutics
Feb 19, 2026, 07:58 ET The Academy for Health & Lifespan Research and Avanti Capital Announce 2026 Viviana Goren Khazzam Communications Fellows
dedication to science outreach.Dr. Jessica Foley, PhD: Postdoctoral fellow in the Promislow Lab at Tufts University, bridging scientific discovery with broader cultural conversations.Dr. Noga Touitou, PhD: Researcher in the laboratory of Prof. Haim Cohen at Bar-Ilan University,
More news about: Academy for Health & Lifespan Research
Feb 19, 2026, 07:33 ET Vie Ventures Names Jeff Bluestone, PhD, as Managing Director
and immune-mediated diseases, today announced that Jeff Bluestone, PhD, has been named Managing Director, joining founders Steven St. Peter, MD, and Luke Evnin, PhD, who also serve as Managing Directors. Together with Lou DeGennaro, PhD, Senior Advisor, Vie's leadership brings complementary expertise spanning
More news about: Vie Ventures
Feb 19, 2026, 07:17 ET Boyd präsentiert seine Führungsrolle im Bereich Flüssigkeitskühlung auf der Data Centre World London 2026
Flüssigkeitskühlsysteme für KI-Rechenzentren, Colocation-Umgebungen und Hyperscale-Betreiber vorstellen. Boyd wird auch einen Vortrag von Ryan J. McGlen, CEng, PhD, präsentieren, der unter dem Titel „Architecting the Data Center Cooling Circuit from ‚Chip-to-Ambient'™" technische Einblicke in das zukünftige Design
More news about: Boyd Corporation
Feb 19, 2026, 07:00 ET NexWafe and Talon PV Announce a Strategic Partnership and Wafer Supply Agreement to Advance Next-Generation TOPCon Solar Manufacturing in the United States
PV represents an important step toward building a next-generation wafer-to-cell ecosystem spanning Germany and the United States," said Davor Sutija, PhD, CEO of NexWafe. "NexWafe is committed to enabling high-efficiency solar manufacturing through advanced substrates, and we look forward to working with
More news about: Talon PV
Feb 19, 2026, 07:00 ET Altesa BioSciences Closes Oversubscribed $75 Million Series B Financing to Transform Treatment of Chronic Lung Diseases
exacerbations represent one of the most significant and underserved drivers of morbidity in COPD and other chronic lung diseases," said Jon Edwards, PhD, Forbion Partner. "Altesa's vapendavir is a first-in-class approach that targets the underlying viral cause of these events, with the potential to meaningfully
More news about: Altesa Biosciences Inc.
Feb 19, 2026, 04:05 ET Boyd to Showcase Liquid Cooling Leadership at Data Centre World London 2026
designed for AI data centers, colocation environments, and hyperscale operators. Boyd will also feature a speaking session from Ryan J. McGlen, CEng, PhD, who will present "Architecting the Data Center Cooling Circuit from 'Chip-to-Ambient'™", offering technical insights into future liquid cooling design
More news about: Boyd Corporation
Feb 18, 2026, 11:30 ET Beckman Foundation Elects New Board Chair, Three Members to Board of Directors
Orange County with accounting and tax advice.Kent Hill, PhD – Dr. Hill is a Professor of Microbiology, Immunology & Molecular Genetics at UCLA and a former Beckman Young Investigator Awardee.Jeffrey S. Moore, PhD – Dr. Moore is the Stanley O. Ikenberry Endowed Chair Emeritus at
More news about: Arnold and Mabel Beckman Foundation